<?xml version="1.0" encoding="UTF-8"?>
<results title="sars_covid_2">
 <result pre="existing effective intervention is lacking. The necessary attributes for transfusion" exact="transmission" post="were outlined including: presence of the agent in blood"/>
 <result pre="Sixty-eight such agents were identified with enough evidence/likelihood of transfusion" exact="transmission" post="(e.g., blood phase) and potential for clinical disease to"/>
 <result pre="information on: agent classification; disease agent's importance; clinical syndromes/diseases caused;" exact="transmission" post="modes (including vectors/reservoirs); likelihood of transfusion transmission, and if"/>
 <result pre="XMRV, human parvoviruses/bocaviruses other than B19, and most recently the" exact="Middle East respiratory syndrome" post="coronavirus, MERS-CoV) were added and 14 existing FSs updated"/>
 <result pre="or existing threats to blood safety include the newly described" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV), dengue viruses, chikungunya virus and hepatitis E"/>
 <result pre="they represent a diverse group of agents, infect by multiple" exact="transmission" post="routes, may result in acute or chronic infections, derive"/>
 <result pre="importantly, their emergence is unpredictable. The necessary attributes for transfusion" exact="transmission" post="include the following: presence of the agent in blood"/>
 <result pre="to blood safety; each agent had enough evidence/likelihood of transfusion" exact="transmission" post="(e.g. blood phase) and potential for clinical disease to"/>
 <result pre="background on the disease agent's importance; the clinical syndromes/diseases caused;" exact="transmission" post="modes (including vectors/reservoirs); likelihood of transfusion transmission, and if"/>
 <result pre="in the US, Erhlichia including the first report of transfusion" exact="transmission" post="in the US, B. microti with data reported for"/>
 <result pre="viruses, chikungunya virus and HEV; each will be briefly reviewed." exact="MERS-CoV" post="The MERS-CoV agent is a betacoronavirus first described in"/>
 <result pre="virus and HEV; each will be briefly reviewed. MERS-CoV The" exact="MERS-CoV" post="agent is a betacoronavirus first described in September 2012"/>
 <result pre="disease was first recognized in Nov 2002 [ 8, 9]." exact="Middle East respiratory syndrome" post="coronavirus also likely represents a zoonotic agent that infected"/>
 <result pre="disease. To 30 November 2013, as reported by the US" exact="Centers for Disease Control and Prevention" post="(CDC) and the World Health Organization (WHO), ten countries"/>
 <result pre="deaths have occurred; travel of infected patients with limited person-to-person" exact="transmission" post="are responsible for cases reported elsewhere. Although it appears"/>
 <result pre="was ultimately sourced to one community-acquired case [ 11]. Updated" exact="MERS-CoV" post="rapid risk assessments are routinely published by the European"/>
 <result pre="to blood safety, careful surveillance is required as risk involving" exact="MERS-CoV" post="is rapidly evolving at present. To date, only one"/>
 <result pre="donors including 110 in Saudi Arabia; all were nonreactive for" exact="MERS-CoV" post="neutralizing antibodies [ 12]. There is no evidence of"/>
 <result pre="of the global burden of dengue during the 2010 worldwide" exact="pandemic" post="was 390 million infections across four continents of which"/>
 <result pre="number of viremic donations and the risk of dengue transfusion" exact="transmission" post="have been modelled by the CDC. The resulting model"/>
 <result pre="was believed to be due to a mutation affecting the" exact="viral envelope" post="protein allowing replication in an alternate mosquito vector, A."/>
 <result pre="to 1500 per 100 000 donations [ 17]; however, transfusion" exact="transmission" post="was never documented. What is notable in the islands"/>
 <result pre="to validate a risk assessment tool developed to provide quantitative" exact="transmission" post="estimates of EID risks through blood transfusion. The output"/>
 <result pre="was tested, in which two suspect cases of HEV transfusion" exact="transmission" post="were investigated but neither could be confirmed. In one"/>
 <result pre="represent a wide variety of agents with diverse characteristics, epidemiology," exact="transmission" post="routes and very different risks leading to differing considerations"/>
 <result pre="Yu M et al. Bats are natural reservoirs of SARS-like" exact="coronaviruses" post="Science 2005 310 676 679 doi: 10.1126/science.1118391 16195424 9"/>
 <result pre="et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese" exact="horseshoe bats" post="Proc Natl Acad Sci USA 2005 102 14040 14045"/>
 <result pre="Sci USA 2005 102 14040 14045 16169905 10 collab: US" exact="Centers for Disease Control and Prevention" post="Updated information on the epidemiology of Middle East respiratory"/>
 <result pre="Disease Control and Prevention Updated information on the epidemiology of" exact="Middle East respiratory syndrome" post="coronavirus (MERS-CoV) Infection and guidance for the public, clinicians,"/>
 <result pre="McGeer A Perl TM et al. collab: for the KSA" exact="MERS-CoV" post="Investigation Team Hospital outbreak of Middle East respiratory syndrome"/>
 <result pre="collab: for the KSA MERS-CoV Investigation Team Hospital outbreak of" exact="Middle East respiratory syndrome" post="coronavirus N Engl J Med 2013 369 407 416"/>
 <result pre="blood donors identified by RNA and detection of dengue transfusion" exact="transmission" post="during the 2007 dengue outbreak in Puerto Rico Transfusion"/>
 <result pre="Janssen MP van der Poel CL et al. Modeling the" exact="transmission" post="risk of emerging infectious diseases through blood transfusion Transfusion"/>
 <result pre="RNA in 1939 donors tested and no evidence of HEV" exact="transmission" post="to 362 prospectively followed recipients Transfusion 2013 53 2505"/>
</results>
